Send me a link:

*Text messaging rates may apply.

 Dow Up 0.36% Nasdaq Up 0.71%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
5.89 Down 0.01(0.17%) Jul 22, 4:00PM EDT
Prev Close:5.90
Open:5.97
Bid:5.67 x 100
Ask:6.50 x 2000
1y Target Est:13.40
Beta:1.21
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:5.86 - 6.10
52wk Range:2.05 - 8.25
Volume:788,492
Avg Vol (3m):2,351,180
Market Cap:609.06M
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MACK

Comparison

Symbol% ChgMkt Cap
MACKDown 0.17%609.06M
IMMUUp 1.78%286.43M
LRUSFUp 7.10%61.16M
THLDUp 1.45%249.25M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Jun-14) :-0.30
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-0.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback